Literature DB >> 17893140

Mechanism of transcriptional activation by the proto-oncogene Twist1.

Kristian Bruun Laursen1, Esther Mielke, Philip Iannaccone, Ernst-Martin Füchtbauer.   

Abstract

Mammalian Twist1, a master regulator in development and a key factor in tumorigenesis, is known to repress transcription by several mechanisms and is therefore considered to mediate its function mainly through inhibition. A role of Twist1 as transactivator has also been reported but, so far, without providing a mechanism for such an activity. Here we show that heterodimeric complexes of Twist1 and E12 mediate E-box-dependent transcriptional activation. We identify a novel Twist1 transactivation domain that coactivates together with the less potent E12 transactivation domain. We found three specific residues in the highly conserved WR domain to be essential for the transactivating function of murine Twist1 and suggest an alpha-helical structure of the transactivation domain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893140     DOI: 10.1074/jbc.M707085200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Regulation of cell proliferation and migration by p62 through stabilization of Twist1.

Authors:  Lei Qiang; Baozhong Zhao; Mei Ming; Ning Wang; Tong-Chuan He; Seungmin Hwang; Andrew Thorburn; Yu-Ying He
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

2.  Nonsense mutations of the bHLH transcription factor TWIST2 found in Setleis Syndrome patients cause dysregulation of periostin.

Authors:  Hector L Franco; Jose J Casasnovas; Ruth G Leon; Robert Friesel; Yongchao Ge; Robert J Desnick; Carmen L Cadilla
Journal:  Int J Biochem Cell Biol       Date:  2011-07-27       Impact factor: 5.085

3.  TWIST1 silencing enhances in vitro and in vivo osteogenic differentiation of human adipose-derived stem cells by triggering activation of BMP-ERK/FGF signaling and TAZ upregulation.

Authors:  Natalina Quarto; Kshemendra Senarath-Yapa; Andrea Renda; Michael T Longaker
Journal:  Stem Cells       Date:  2015-03       Impact factor: 6.277

Review 4.  Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms.

Authors:  Qian Qin; Young Xu; Tao He; Chunlin Qin; Jianming Xu
Journal:  Cell Res       Date:  2011-08-30       Impact factor: 25.617

5.  The Aurora-A-Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma.

Authors:  Jing Wang; Kumar Nikhil; Keith Viccaro; Lei Chang; Max Jacobsen; George Sandusky; Kavita Shah
Journal:  J Cell Sci       Date:  2017-02-06       Impact factor: 5.285

6.  Loss of Twist1 in the Mesenchymal Compartment Promotes Increased Fibrosis in Experimental Lung Injury by Enhanced Expression of CXCL12.

Authors:  Jiangning Tan; John R Tedrow; Mehdi Nouraie; Justin A Dutta; David T Miller; Xiaoyun Li; Shibing Yu; Yanxia Chu; Brenda Juan-Guardela; Naftali Kaminski; Kritika Ramani; Partha S Biswas; Yingze Zhang; Daniel J Kass
Journal:  J Immunol       Date:  2017-02-08       Impact factor: 5.422

7.  Interactions between Twist and other core epithelial-mesenchymal transition factors are controlled by GSK3-mediated phosphorylation.

Authors:  Rachel Lander; Talia Nasr; Stacy D Ochoa; Kara Nordin; Maneeshi S Prasad; Carole Labonne
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  CCL2 in the Tumor Microenvironment.

Authors:  Tracy O'Connor; Mathias Heikenwalder
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  A twist of insight - the role of Twist-family bHLH factors in development.

Authors:  Ralston M Barnes; Anthony B Firulli
Journal:  Int J Dev Biol       Date:  2009       Impact factor: 2.203

10.  The twist box domain is required for Twist1-induced prostate cancer metastasis.

Authors:  Rajendra P Gajula; Sivarajan T Chettiar; Russell D Williams; Saravanan Thiyagarajan; Yoshinori Kato; Khaled Aziz; Ruoqi Wang; Nishant Gandhi; Aaron T Wild; Farhad Vesuna; Jinfang Ma; Tarek Salih; Jessica Cades; Elana Fertig; Shyam Biswal; Timothy F Burns; Christine H Chung; Charles M Rudin; Joseph M Herman; Russell K Hales; Venu Raman; Steven S An; Phuoc T Tran
Journal:  Mol Cancer Res       Date:  2013-08-27       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.